Combined experimental and quantitative structure inter-activity relationship (QSIAR) computation methods were advanced in order to establish the structural and mechanistic influences that steroids and triterpenes, either as newly synthesized or naturally isolated products, have on human HT1080 mammalian cancer cells. The main Hansch structural indicators such as hydrophobicity (LogP), polarizability (POL) and total energy (Etot) were considered and both the structure-projected as well as globally computed correlations were reported; while the inter-activity correlation of the global activity with those projected on structural information was revealed as equal to the direct structural-activity one for the trial sets of compounds, the prediction for the testing set of molecules reported even superior performances respecting those characteristic for the calibration set, validating therefore the present QSInAR models; accordingly, it follows that the LogP carries the most part of the cytotoxic signal, while POL has little influence on inhibiting tumor growth—A complementary behavior with their earlier known influence on genotoxic carcinogenesis. Regarding the newly hemisynthetic compounds it was found that stigmasta-4,22-dien-3-one is not adapted for cell membrane diffusion; it is recommended that aminocinnamyl chlorohydrate be further modified in order to acquire better steric influence, while aminocinnamyl-2,3,4,6-O-tétraacétyl-α-D-glucopyranoside was identified as being inhibited in the tumor cell by other molecular mechanisms–here not revealed–although it has a moderate-high anti-cancer structurally predicted activity.
为了确定类
固醇和三
萜类化合物(无论是新合成的还是天然分离的产品)对人类 HT1080 哺乳动物癌细胞的结构和机理影响,我们采用了实验和定量结构间活性关系(QSIAR)计算相结合的方法。我们考虑了主要的 Hansch 结构指标,如疏
水度 (LogP)、极化性 (POL) 和总能 (Etot),并报告了结构预测和全局计算的相关性;全局活性与根据结构信息预测的活性之间的相关性与试验组化合物的直接结构-活性之间的相关性相同,而对测试组分子的预测报告甚至优于校准组的预测报告,从而验证了目前的 QSInAR 模型;因此,LogP 带有大部分细胞毒性信号,而 POL 对抑制肿瘤生长的影响很小--这与早先已知的 POL 对
基因毒性致癌的影响是互补的。关于新的半合成化合物,发现
石杉碱甲-4,22-二烯-3-酮不适合细胞膜扩散;此外,还发现
氨肉桂基-2,3,4,6-O-tétraacétyl-α-
D-吡喃葡萄糖苷可通过其他分子机制抑制肿瘤细胞--在此尚未揭示--尽管从结构上预测其具有中等偏上的抗癌活性。